Biological activity comparative evaluation of the gene-activated bone substitutes made of octacalcium phosphate and plasmid DNA carrying VEGF and SDF genes: part 2 - in vivo

Autor:	G.A. Volozhin, S. I. Rozhkov, O.V. Savva, Vladimir S. Komlev, I.Y. Bozo, A. Y. Drobyshev, Roman V. Deev, I.I. Eremin, Vladimir K. Popov, Isaev Artur Aleksandrovich, Igor V. Smirnov
Rok vydání:	2017
Předmět:	Transplantation biology VEGF receptors Biomedical Engineering Biological activity Cell Biology Comparative evaluation chemistry.chemical_compound Plasmid dna chemistry Biochemistry In vivo biology.protein Surgery Octacalcium phosphate Molecular Biology Gene Biotechnology
Zdroj:	Genes & Cells. 12:39-46
ISSN:	2500-2562 2313-1829
DOI:	10.23868/201707028
Popis:	Bone substitutes with osteoinductive and (or) osteogenic capacities are highly needed in clinical practice for treatment of patients with skeletal bone pathology. Gene-activated bone substitutes consisting of a scaffold and gene constructs belong to such materials. In this study, we made two proto-types of gene-activated bone substitutes based on octacalcium phosphate (OCP) granules and two variants of plasmid DNA - the system delivering single gene encoding vascular endothelial growth factor A-165 (VEGFA-165, pl-VEGFA) and the other plasmid carrying simultaneously VEGFA and gene of stromal-derived factor 1a (pl-VEGFA-SDF). All the materials were implanted to rabbits into the full-thickness parietal bone defects with diameter 10 mm, OCP without plasmid DNA we used as a control. Both gene-activated materials showed pronounced osteoinduction providing new bone formation in the central part of the defects and complete parietal bone repair by 90 days after surgery. In addition, we found newly formed bone level to be higher in pl-VEGFA-SDF group comparing with pl-VEGFA (p
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::6bde561d6790953c3ca3e0cf4f1f0a4c https://doi.org/10.23868/201707028 Zobrazit plný text záznamu